Nebivolol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Nebivolol and local guidelines before prescribing.
Beta-1 selective blocker
Mechanism
Cardioselective beta blocker with nitric oxide-mediated vasodilation.
Uses
Hypertension, heart failure in older people.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Bradycardia, headache, fatigue, dizziness.
Interactions
Verapamil and diltiazem; clonidine; amiodarone.
Contraindications and cautions
Asthma, heart block, severe bradycardia
Monitoring
Pulse, BP
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Atropine, glucagon
Special advice
Do not stop abruptly; caution in asthma.
More from the textbook: uses, cautions and other points
- Cardioselective (beta-1) - bisoprolol, metoprolol, atenolol, nebivolol.
Cardiology: Anatomy Physiology and Pharmacology - Uses - angina, after MI, HFrEF (bisoprolol, carvedilol, nebivolol, metoprolol succinate -"start low, go slow"), AF rate control, SVT, hypertension (not first-line alone), thyrotoxicosis.
Cardiology: Anatomy Physiology and Pharmacology - Evidence-based agents : Bisoprolol. Carvedilol. Metoprolol succinate modified-release. Nebivolol in selected patients.
Cardiology: Heart Failure › 2.19 💊 Beta Blockers
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Heart Failure (1 mention)
- Integrated cardiology chapter (1 mention)